DBV Technologies (DBVT) Share-based Compensation (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Share-based Compensation of $3.7 million for Q2 2026, up 208.33% year-on-year from $1.2 million in Q2 2025, and up 60.87% on a QoQ basis from $2.3 million in Q1 2026.

DBV Technologies (DBVT) Share-based Compensation (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Share-based Compensation for 7 consecutive years, with $3.7 million the latest figure, recorded in Q2 2026.

  • Quarterly Share-based Compensation rose 208.33% year-over-year to $3.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.5 million (up 110.23% YoY) and the FY2025 annual result came in at $5.4 million, up 16.6% from the prior year.
  • Share-based Compensation advanced to $3.7 million in Q2 2026 per DBVT's latest filing, from $2.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for DBVT reached as high as $3.7 million in Q2 2026 and fell as low as -$453000.0 in Q4 2024.
  • A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2024 — Share-based Compensation sank 137.16% — and 2025, when it surged 524.72%.
  • Year by year, Share-based Compensation stood at $1.6 million in 2022, then declined by 24.29% to $1.2 million in 2023, then slumped by 137.16% to -$453000.0 in 2024, then jumped by 524.72% to $1.9 million in 2025, then soared by 92.31% to $3.7 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $3.7 million, $2.3 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 3.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.70 Mn
Jun 30, 2026 3.70 Mn
Mar 31, 2026 2.30 Mn
Mar 31, 2026 2.30 Mn
Dec 31, 2025 1.92 Mn
Dec 31, 2025 1.92 Mn
Sep 30, 2025 563,000.00
Sep 30, 2025 563,000.00
Jun 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.70 Mn
Mar 31, 2025 1.70 Mn
Dec 31, 2024 -453,000.00
Dec 31, 2024 -453,000.00
Sep 30, 2024 1.59 Mn
Sep 30, 2024 1.59 Mn
Jun 30, 2024 1.53 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 1.96 Mn
Mar 31, 2024 1.96 Mn